140 related articles for article (PubMed ID: 1748979)
21. Prognostic indicators for naïve canine non-indolent T-cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy.
Blaxill J; Buzzacott P; Finlay J
Vet Comp Oncol; 2022 Mar; 20(1):215-226. PubMed ID: 34464024
[TBL] [Abstract][Full Text] [Related]
22. A comparison of serum ionized calcium concentrations and serum total calcium concentrations in dogs with lymphoma.
Teachout DJ; Taylor SM; Archer FJ
Zentralbl Veterinarmed A; 1997 Jun; 44(4):195-200. PubMed ID: 9270341
[TBL] [Abstract][Full Text] [Related]
23. Utility of a multiple serum biomarker test to monitor remission status and relapse in dogs with lymphoma undergoing treatment with chemotherapy.
Alexandrakis I; Tuli R; Ractliffe SC; Tappin SW; Foale RD; Roos A; Slater KJ
Vet Comp Oncol; 2017 Mar; 15(1):6-17. PubMed ID: 25319380
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the effects of asparaginase administered subcutaneously versus intramuscularly for treatment of multicentric lymphoma in dogs receiving doxorubicin.
Valerius KD; Ogilvie GK; Fettman MJ; Walton JA; Richardson K; Powers BE; McNiel EA; Rogers QR
J Am Vet Med Assoc; 1999 Feb; 214(3):353-6. PubMed ID: 10023395
[TBL] [Abstract][Full Text] [Related]
25. Etoposide (VP-16). Retrospective analysis of treatment in 13 dogs with lymphoma.
Hohenhaus AE; Matus RE
J Vet Intern Med; 1990; 4(5):239-41. PubMed ID: 2262925
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of peripheral blood and bone marrow infiltration in newly-diagnosed canine nodal marginal zone lymphoma.
Marconato L; Comazzi S; Aresu L; Riondato F; Stefanello D; Ferrari R; Martini V
Vet J; 2019 Apr; 246():78-84. PubMed ID: 30902194
[TBL] [Abstract][Full Text] [Related]
27. Treatment of canine lymphoma with COPLA/LVP.
Boyce KL; Kitchell BE
J Am Anim Hosp Assoc; 2000; 36(5):395-403. PubMed ID: 10997514
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of combination chemotherapy for treatment of gastrointestinal lymphoma in dogs.
Rassnick KM; Moore AS; Collister KE; Northrup NC; Kristal O; Chretin JD; Bailey DB
J Vet Intern Med; 2009; 23(2):317-22. PubMed ID: 19192147
[TBL] [Abstract][Full Text] [Related]
29. Impact of chemotherapeutic dose intensity and hematologic toxicity on first remission duration in dogs with lymphoma treated with a chemoradiotherapy protocol.
Vaughan A; Johnson JL; Williams LE
J Vet Intern Med; 2007; 21(6):1332-9. PubMed ID: 18196744
[TBL] [Abstract][Full Text] [Related]
30. High-mobility group B1 proteins in canine lymphoma: prognostic value of initial and sequential serum levels in treatment outcome following combination chemotherapy.
Meyer A; Eberle N; Bullerdiek J; Nolte I; Simon D
Vet Comp Oncol; 2010 Jun; 8(2):127-37. PubMed ID: 20579326
[TBL] [Abstract][Full Text] [Related]
31. Pseudohyperparathyroidism in the dog.
Osborne CA; Stevens JB
J Am Vet Med Assoc; 1973 Jan; 162(2):125-35. PubMed ID: 4683804
[No Abstract] [Full Text] [Related]
32. Efficacy of a continuous, multiagent chemotherapeutic protocol versus a short-term single-agent protocol in dogs with lymphoma.
Simon D; Moreno SN; Hirschberger J; Moritz A; Kohn B; Neumann S; Jurina K; Scharvogel S; Schwedes C; Reinacher M; Beyerbach M; Nolte I
J Am Vet Med Assoc; 2008 Mar; 232(6):879-85. PubMed ID: 18341445
[TBL] [Abstract][Full Text] [Related]
33. Hypercalcemia associated with blastomycosis in dogs.
Dow SW; Legendre AM; Stiff M; Greene C
J Am Vet Med Assoc; 1986 Apr; 188(7):706-9. PubMed ID: 3700225
[TBL] [Abstract][Full Text] [Related]
34. Multicentric canine lymphoma in a 12-year-old keeshond: chemotherapy options.
Martineau MM
Can Vet J; 2002 Sep; 43(9):709-11. PubMed ID: 12240530
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of mitoxantrone for the treatment of lymphoma in dogs.
Moore AS; Ogilvie GK; Ruslander D; Rand WS; Cotter SM; Getzy DM; L'Heureux DA; Dennis RA
J Am Vet Med Assoc; 1994 Jun; 204(12):1903-5. PubMed ID: 8077132
[TBL] [Abstract][Full Text] [Related]
36. Assessment of anemia as an independent predictor of response to chemotherapy and survival in dogs with lymphoma: 96 cases (1993-2006).
Abbo AH; Lucroy MD
J Am Vet Med Assoc; 2007 Dec; 231(12):1836-42. PubMed ID: 18081522
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis, assessment of prognosis, and treatment of dogs with lymphoma: the sentinel changes (1973-1999).
Madewell BR
J Vet Intern Med; 1999; 13(5):393-4. PubMed ID: 10499718
[No Abstract] [Full Text] [Related]
38. Suspected primary bone marrow T-cell lymphoid neoplasia causing paraneoplastic hypercalcemia in 11 dogs (2014-2021).
Portanova A; Rout ED; Avery AC; Viall AK
J Am Vet Med Assoc; 2024 Mar; 262(3):1-9. PubMed ID: 37922707
[TBL] [Abstract][Full Text] [Related]
39. Phase II clinical trial of combination chemotherapy with dexamethasone for lymphoma in dogs.
Greenberg CB; Boria PA; Borgatti-Jeffreys A; Raskin RE; Lucroy MD
J Am Anim Hosp Assoc; 2007; 43(1):27-32. PubMed ID: 17209082
[TBL] [Abstract][Full Text] [Related]
40. A Quick Reference on Hypercalcemia.
de Brito Galvão JF; Schenck PA; Chew DJ
Vet Clin North Am Small Anim Pract; 2017 Mar; 47(2):241-248. PubMed ID: 28012787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
